Invitrogen Invests $3.4M in Illumina, Gains Oligator Marketing Rights | GenomeWeb

This article has been updated from a previous version to include comments from company officials.

 

NEW YORK, Dec. 20 (GenomeWeb News) - Invitrogen and Illumina today announced a collaboration to distribute Illumina's Oligator DNA synthesis technology through Invitrogen's marketing channels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.